EpiVax, Inc. - Informatics and Immunology
  • Our Company
    • Company Overview
    • Corporate Responsibility
    • Mission, Vision & Values
    • Team
    • Careers
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • BioDefense Vaccines
    • Tregitope: Immunomodulation Power Tool
    • Deimmunization Projects
  • Vaccine Services
    • Vaccine Services
    • iVAX: Web-based Vaccine Design
    • PreVAX Analysis
    • EpiCC
  • Immunogenicity Assessment
    • Immunogenicity Assessment Overview
    • ISPRI Web-based Immunogenicity Assessment
    • PreDeFT Analysis
    • High Throughput Immunogenicity Analysis
    • PANDA Screening
    • ISPRI for Host Cell Proteins
    • Deimmunization
    • Trusted Expert Advice (TEA) Consulting Services
  • Lab Services
    • Lab Services Overview
    • HLA Binding Assays
    • T Cell Assays
  • Press Room
    • Press Room
    • Events
      • Webinars
    • Publication & Poster Search
    • Client Testimonials
    • Thinking Out Loud (Blog)
    • Recipes For Success (Podcast)
  • Contact Us
Select Page
AAPS NBC Tech Challenge Talk: Engineering Better Biologics: Does Nature Know Best?

AAPS NBC Tech Challenge Talk: Engineering Better Biologics: Does Nature Know Best?

by Riley Nolan | May 21, 2021 | Events, Featured, Webinars

EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021. Outline:  Background on T cells / Immunogenicity EpiMatrix, JanusMatrix ...
AAPS BPABC Community Presentation: In silico Immunogenicity Prediction for Protein and Peptide Therapeutics

AAPS BPABC Community Presentation: In silico Immunogenicity Prediction for Protein and Peptide Therapeutics

by Riley Nolan | Mar 11, 2021 | Events, Featured, Webinars

Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is...
FDA Webinar: Epitope Selection for Cancer Vaccines

FDA Webinar: Epitope Selection for Cancer Vaccines

by Riley Nolan | Feb 17, 2021 | Events, Featured, Webinars

EpiVax CEO/CSO Annie De Groot hosted a talk for the FDA Office of Tissues and Advanced Therapies (OTAT) group on February 11, 2021. Annie presented the latest on EpiVax’s iVAX Toolkit in her talk “Epitope Selection for Cancer Vaccines”. JanusMatrix,...
FDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling

FDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling

by Riley Nolan | Jan 26, 2021 | Events, Featured, Webinars

The FDA hosted a virtual workshop January 26, 2021 to provide updates and foster discussions around non-clinical assays for comparative immunogenicity risk assessment of generic peptide products. EpiVax CEO/CSO, Annie De Groot, presented an update on EpiVax’s...
EpiVax CEO/CSO Annie De Groot wins AAPS 2020 Global Health Award

EpiVax CEO/CSO Annie De Groot wins AAPS 2020 Global Health Award

by Riley Nolan | Oct 20, 2020 | Uncategorized, Webinars

We are excited to share that our very own Annie De Groot was selected as a recipient of this year’s AAPS Global Health Award! View Annie’s acceptance speech here! The American Association of Pharmaceutical Scientists(AAPS) nominates one member annually for...
PANDA: Immunogenicity of Peptide Drugs Webinar with Live Q&A

PANDA: Immunogenicity of Peptide Drugs Webinar with Live Q&A

by Annie De Groot | Sep 23, 2020 | Events, Webinars

Catch the replay We’re sorry, but this live event has passed.  You may watch the replay here. The video is hosted by Dropbox, in which case you will need to either be logged in to an account, or downlow the video in order to view the full recording.  Should you...
« Older Entries

Recent Posts

  • From Kyoto, with Love
  • EpiVax Turns 25!
  • Happy Valentine’s Day! And don’t argue with Chatbots!
  • ISPRI in silico Toolkit in the Literature
  • Platform shoes, Bellbottoms and #CrueltyFreeFDA!

Categories

  • EpiVax Immunoncology
  • Events
  • Featured
  • News
  • Recipes for Success – Vlog
  • Thinking Out Loud -Blog
  • Uncategorized
  • Webinars

Discover

  • Vaccine Services
  • Immunogenicity Assessment
  • Deimmunization
  • Lab Services
  • Pipeline

About

  • Our Company
  • Press Room
  • Events
  • Publication & Poster Search
  • Thinking Out Loud (Blog)
  • Contact Us

Connect

© 2023 EpiVax, Inc. – Informatics and Immunology, All rights reserved. Privacy Policy • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 • fax: 401.272.7562